There are 2789 resources available
116P - Real-world and in silico incidence of fibroblast growth factor receptor (FGFR) 1-4 molecular alterations across multiple cancer types
Presenter: Laura Angelats
Session: ePoster Display
165P - Pathologic and immunohistochemical prognostic score in residual triple-negative breast cancer after neoadjuvant chemotherapy
Presenter: Silvia Mihaela Ilie
Session: ePoster Display
166P - Hereditary breast, ovarian and pancreatic cancers: Looking beyond the BRCA1/2 genes
Presenter: Marco Bono
Session: ePoster Display
127P - The mutational landscape, oncogenic pathways and mutational signatures of breast neuroendocrine tumors
Presenter: Peeter Karihtala
Session: ePoster Display
283P - Treatment landscape of HER2-positive metastatic breast cancer (MBC): Results from the Austrian AGMT_MBC-Registry
Presenter: Simon Peter Gampenrieder
Session: ePoster Display
284P - Trastuzumab emtansine (T-DM1) in Asian patients with previously treated HER2-positive locally advanced (LA) or metastatic breast cancer (MBC): Data from the phase III EMILIA study
Presenter: Seock-Ah Im
Session: ePoster Display
285P - Real-world outcomes associated with pyrotinib-based therapy for HER2-positive metastatic breast cancer
Presenter: Li Hao
Session: ePoster Display
286P - Outcome of patients with HER2-positive brain metastatic breast cancer: A 10-year retrospective study
Presenter: Cecile Bigot
Session: ePoster Display
174P - Better survival associated with successful vitamin D supplementation in non-metastatic breast cancer survivors
Presenter: Elif Isbilen
Session: ePoster Display
288P - Real-world outcomes and safety of pyrotinib in HER2-positive metastatic breast cancer (MBC) patients: A prospective cohort study
Presenter: Ting Luo
Session: ePoster Display